- Home
- IH vs OBIO Comparison
IH vs OBIO Comparison
Compare IH & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IH
- OBIO
- Stock Information
- Founded
- IH 1996
- OBIO 2017
- Country
- IH China
- OBIO United States
- Employees
- IH N/A
- OBIO N/A
- Industry
- IH Other Consumer Services
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- IH Real Estate
- OBIO Health Care
- Exchange
- IH Nasdaq
- OBIO Nasdaq
- Market Cap
- IH 146.3M
- OBIO 147.8M
- IPO Year
- IH 2020
- OBIO N/A
- Fundamental
- Price
- IH $3.07
- OBIO $2.46
- Analyst Decision
- IH
- OBIO Strong Buy
- Analyst Count
- IH 0
- OBIO 4
- Target Price
- IH N/A
- OBIO $14.00
- AVG Volume (30 Days)
- IH 18.1K
- OBIO 247.4K
- Earning Date
- IH 09-22-2025
- OBIO 11-11-2025
- Dividend Yield
- IH 2.85%
- OBIO N/A
- EPS Growth
- IH N/A
- OBIO N/A
- EPS
- IH 0.26
- OBIO N/A
- Revenue
- IH $123,701,096.00
- OBIO $2,944,000.00
- Revenue This Year
- IH $39.02
- OBIO $29.26
- Revenue Next Year
- IH N/A
- OBIO $10.65
- P/E Ratio
- IH $11.26
- OBIO N/A
- Revenue Growth
- IH N/A
- OBIO 41.61
- 52 Week Low
- IH $1.47
- OBIO $2.37
- 52 Week High
- IH $3.60
- OBIO $6.50
- Technical
- Relative Strength Index (RSI)
- IH 60.00
- OBIO 38.14
- Support Level
- IH $2.80
- OBIO $2.57
- Resistance Level
- IH $3.16
- OBIO $2.68
- Average True Range (ATR)
- IH 0.16
- OBIO 0.13
- MACD
- IH 0.03
- OBIO -0.02
- Stochastic Oscillator
- IH 85.40
- OBIO 2.04
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.